![](/img/cover-not-exists.png)
A phase 2, randomized, placebo-controlled study of the efficacy and safety of TAK-063 in subjects with an acute exacerbation of schizophrenia
Macek, Thomas A., McCue, Maggie, Dong, Xinxin, Hanson, Elizabeth, Goldsmith, Paul, Affinito, John, Mahableshwarkar, Atul R.Language:
english
Journal:
Schizophrenia Research
DOI:
10.1016/j.schres.2018.08.028
Date:
September, 2018
File:
PDF, 500 KB
english, 2018